title: Randomized, placebo-controlled trial or post hoc subgroup analysis: the importance of standardized and comprehensive reporting.
authors.forename: André
authors.initials: A
authors.lastname: Karch
authors.forename: Ralf
authors.initials: R
authors.lastname: Krumkamp
authors.forename: Benno
authors.initials: B
authors.lastname: Kreuels
mesh_terms: D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism*; D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000008:administration & dosage*; D016325:HIV Long Terminal Repeat / Q000235:genetics*; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D008297:Male; D011760:Pyrrolidinones / Q000008:administration & dosage*
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D019428:HIV Integrase Inhibitors; D011760:Pyrrolidinones